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Abstract 
Chikungunya virus (CHIKV) has been previously reported in many African and Asian areas, but it 
recently reemerged strongly in countries bordering the Indian Ocean as well as caused an outbreak in 
northern Italy. In Germany, where potential CHIKV vectors are not yet established, CHIKV infection is 
mandatorily notifiable. Cases reported from 2006 through 2009 were analyzed for travel characteristics 
and demographic factors. 152 cases of symptomatic CHIKV infection were notified. Both sexes were 
affected, with a median age of 46 years. Over the years, countries of infection largely followed the 
outbreaks reported from various travel destinations. India and the Maldives were the countries of 
infection most frequently named. In Sri Lanka, India, and Thailand, which are also frequently named 
countries of infection for dengue virus, the median age of CHIKV-affected patients was higher than 
that of dengue fever patients. Taking traveler numbers into consideration, risk of CHIKV infection was 
higher in the Seychelles and Mauritius than in Thailand and India. Even though substantial 
underdiagnosis is suspected, this assessment of CHIKV importation to Germany offers valuable 
information about the details of travel-associated cases. Between 17 and 53 notified cases per year 
signify that CHIKV would be occasionally available for local transmission in Germany once a vector 
becomes present. Although CHIKV most often causes a comparatively mild disease, the high median 
age of notified cases and the higher age than dengue patients support more severe disease courses 
in older adults. Travelers to all CHIKV endemic areas should protect against mosquito bites. In 
Germany, CHIKV surveillance will be continued to monitor ongoing importation of the virus and to 
detect early potential autochthonous cases. 
 
Introduction 
Chikungunya virus (CHIKV) infections were first described in the mid-1950s in Africa (Lumsden 1955, 
Robinson 1955, Ross 1956). The disease has resurged in recent years, with major epidemics reported 
from countries surrounding the Indian Ocean (Table 1). Although frequently a comparatively mild 
disease, individual severe cases have been observed (Economopoulou et al. 2009, Tandale et al. 
2009) and waves of CHIKV infections have been linked to a subsequent rise in overall population 
mortality (Beesoon et al. 2008). 
From a European perspective, chikungunya fever was a rarely diagnosed imported travel-associated 
infection, until the outbreaks on Réunion and Mauritius rendered European tourists to these islands at 
a suddenly increased risk of infection. Consequently, in 2005 and 2006, especially mainland France 
(Cordel et al. 2006, Krastinova et al. 2006), but also other European nations (Depoortere and 
  
Coulombier 2006), reported a sudden increase in imported CHIKV infections. The need for CHIKV 
surveillance in Europe was driven home by the autochthonous outbreak of CHIKV infections in central 
Italy in 2007 (Rezza et al. 2007, Angelini et al. 2008). There, after introduction of the virus by a traveler 
from India, abundant local Aedes (Ae.) albopictus transmitted the virus and caused an outbreak of 337 
suspected cases (217 confirmed) including one fatality. Ae. albopictus has been introduced to coastal 
Europe in recent decades, established themselves in Mediterranean countries and appear to spread 
further. Consequently, vigilance both of this potential vector and regarding importations of the virus is 
sensible (Straetemans 2008). 
Parts of Germany are considered potential colonization areas for Ae. albopictus (European Centre for 
Disease Prevention and Control 2009). Published case series of German CHIKV cases imported since 
2005 have focused mainly on clinical and diagnostic features (Taubitz et al. 2007, Panning et al. 2008, 
Pfeffer et al. 2008). As CHIKV infections are notifiable in Germany under the Protection Against 
Infection Act of 2001, from 2006 the German national-level database for notifiable infectious disease 
registered cases of CHIKV infections. Laboratories have to notify any diagnosed acute infection to the 
patient's local health department, who then investigates symptoms, dates of onset, possible 
hospitalization, travel details including country of infection, etc. This study aimed to describe all notified 
cases and to interpret the time trends of the infection's importation since its resurgence in the Indian 
Ocean. 
 
Materials and Methods 
In Germany, acute CHIKV infections are notifiable by law. Physicians and laboratories finding 
evidence for an acute infection notify the case to the local health department of the patient's 
residence. Information from both sources, as well as the patient, is collated and recorded. The case 
file—minus name and address information—is passed on to state- and national-level health 
departments electronically within a few days. At the national level, the resulting database is hosted by 
the Robert Koch Institute. Available information on CHIKV infections notified from January 2006 
through December 2009 was extracted and analyzed descriptively with respect to sex, age, type of 
laboratory confirmation, hospitalization, seasonality, and country of infection. Data on dengue virus 
cases from the same period and data source were used for comparisons. Chikungunya fever case 
data were compared with data on the number of travelers embarking to important contributing 
countries of CHIKV infections [source: German Statistical Office (DESTATIS 2006–10)—data available 
monthly through October 2009]. 
 
Results 
In the years 2006 through 2009 (as of January 5, 2010) 152 cases of symptomatic CHIKV infection (at 
least fever) were notified in Germany (17–53 per year): 8 (5.3%) were confirmed by polymerase chain 
reaction, 49 (32.2%) by a significant increase in IgG in between two serum samples, and the 
remainder (62.5%) by a single elevated IgM result. All infections were imported from outside mainland 
Europe (travel within the incubation period). Twenty percent reported hospitalization for between 1 and 
28 days (median: 7 days), but none of the case patients died. 
Earliest onset was on December 29, 2005 and latest was on November 18, 2009. For 110 cases, 
onset could be calculated relative to their return to Germany (for the others, travel history was 
available but without dates): 38 (35%) fell ill upon or after their return, and additional 36 (33%) had 
symptom onset within 7 days before returning to Germany and could have been viremic while back in 
Germany. 
Among the patients, 57% were female. Age ranged from 6 to 77 years (median: 46 years, similar for 
both sexes). Month of disease onset had to be extrapolated for 16 cases—for 14, date of the first 
diagnostic sample was used as a proxy, and for 2, the month of notification. Most cases fell ill in 2006 
(n=56), much fewer in 2007 (n=28) and 2008 (n=20), and an upsurge again in 2009 (n=47). Cases 
occurred throughout the year, with an overall minimum in December and January. There was no clear 
overall seasonality, with peaks shifting from year to year: in 2006 there was one in February through 
May and in 2007 from June through August. There was no peak discernable in 2008. In 2009, case 
numbers increased from July through November. 
  
The countries most frequently named as the origin of the infection were India (n=37), Mauritius (n=34), 
and the Maldives (n=20) (Table 2). However, notifications came in distinct waves (Fig. 1). 
Duration of travel was known for 116 cases and ranged from 4 to 1034 days (median: 19.5 days), 
although only two patients stayed more than a year in the country of infection. Median travel duration 
was notably longer in Sri Lanka, India, the Seychelles, and Thailand than in Mauritius and the 
Maldives. Peak months also varied by country. 
Median age was higher than the overall median in Mauritius and Sri Lanka. It was lower in the 
Maldives and Thailand. As Sri Lanka, India, Thailand, and the Maldives also are frequent countries of 
infection for dengue fever imported to Germany, median age of the notified affected patients with the 
two infections can be compared. For these countries, median age for dengue fever cases is between 4 
(Thailand) and 15 years (India) lower than that of chikungunya fever cases from the respective 
country. 
Taking the annual number of air travelers to the most frequently named countries of infection into 
consideration, the risk to become infected with CHIKV in the 4-year period from 2006 through 2009 
was higher in the Seychelles and Mauritius than in the other countries studied—they were lowest in 
India and Thailand. Even broken down by month, short-term risks reach higher levels in island 
destinations (Fig. 2). 
 
Discussion 
These data provide a first assessment of imported symptomatic CHIKV infections in Germany over the 
course of 4 years. Because of the broad spectrum of disease, substantial underdiagnosis of imported 
CHIKV infections remains likely. However, a stable fraction notified to the surveillance system allows 
to monitor the trends of CHIKV importation into Germany and to estimate the risks for travelers to 
distinct regions. Based on our analysis, the absolute minimum of actual importations to be expected is 
currently 17–53 cases per year. Considering that approximately two-thirds of these cases likely 
experience some viremia while back in Germany (others may have already recovered upon their 
return), the presence of a competent vector mosquito would render local outbreaks, like the one in 
Italy, possible. Ae. albopictus has so far not established itself in Germany, although its ova have been 
found once (in 2007) in the German Southwest (Pluskota et al. 2008) and it has established itself in 
neighboring Switzerland (Wymann et al. 2008). The Netherlands to the West have repeatedly noted 
the importation of Ae. albopictus associated with plant shipments from overseas and, most recently, of 
Ae. albopictus and Ae. aegypti associated with tire shipments (Scholte et al. 2010). 
Physicians ought to include the CHIKV infection in their differential diagnosis of travelers returning 
from subtropical and tropical areas in Africa and Asia who seek medical attention for fever and joint 
pains—regardless of the severity of these symptoms. Increased awareness for this infection among 
physicians would also be a prerequisite for early detection of potential autochthonous cases. 
CHIKV infection is commonly described as a mild disease. That almost a fifth of the notified CHIKV 
infection case patients in Germany were hospitalized for a median duration of a week may be partially 
explained by more severely ill patients' higher propensity to be diagnosed and notified as cases. Quite 
possibly, the underdiagnosis of mild cases also explains a rather high median age of 46 years among 
those notified. A higher age in chikungunya fever patients than in dengue fever patients as found in 
this German group of patients has been previously described in a dual outbreak situation in Sri Lanka 
(Kularatne et al. 2009) and is likely due to more severe disease courses in older CHIKV-affected 
patients (Economopoulou et al. 2009). Similarly observed prolonged recovery in older patients 
(Soumahoro et al. 2009) would infer a higher likelihood of case notification, as among patients with 
disease onset during travel those with a longer duration of symptoms would be more likely to seek 
medical attention upon return to Germany and thus be notified as cases. 
The risk to acquire CHIKV infection is largely driven by the local presence (and the intensity of the 
presence) of the infection. Temporal clusters of German patients coming from specific countries of 
infection are largely synchronous with epidemic waves described in the literature. Thus, the risk of a 
CHIKV infection is particularly high when visiting a small area with a known outbreak, i.e., a small 
island destination or a particular city. As potential areas of CHIKV activity are also frequently endemic 
  
for dengue fever and malaria, travelers need to protect themselves from mosquito bites during the day 
and at night. For unexplained fevers, medical attention should be quickly sought, if only to exclude 
malaria. CHIKV surveillance in Germany will be continued to monitor continuing importation of the 
virus in viremic patients and to receive early notice of potential future cases of autochthonous 
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Tables and Figures 
 




Table 2. Features of Chikungunya Fever Cases and Median Age of Dengue Fever Cases Imported 
from the Most Named Countries of Chikungunya Virus Infection, 2006 to November 2009 
 
a 
First and last cases within the confines of the study period from January 2006 through November 
2009. 
b 
Persons embarking from a German airport to the ticketed destination in 2008 (DESTATIS 2006–10). 
c 
As 2009 traveler numbers are incomplete, data for November and December 2008 were used as 
proxy for those months in 2009. 
d 
Only isolated dengue cases imported from Mauritius and the Seychelles preclude calculation of a 
meaningful median age; similarly, as dengue fever is also common in South and Central America, a 
comparison of the overall median ages is inappropriate. 
e 
Statistically significantly lower median age than the chikungunya cases from that country (Mann–







Figure 1. Major countries of infection named by German patients with chikungunya virus infection, 

























Figure 2. Absolute case numbers by month and year of infection, 2006–2009 (A), and relative risk of 
infection (cases per 100,000 travelers to the country, January 2006 through October 2009) (B) by 
country/country group of infection. 
 
 
 
